Global $18.3 Billion Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market 2014-2017 & 2025

The global pharmacogenomics technology (theranostics and companion diagnostics) market is expected to reach USD 18.3 billion by 2025

Diagnostics is coming to grips with the wave of pharmacogenomic tests that are followed by new biological therapy introductions. These tests enable cost-effective treatment and also add value to the process of drug-development. Advantages associated with the usage of these tests such as disease risk prediction, patient stratification, and therapeutic response monitoring over the traditional methods is anticipated to significant source of progress in this market.

In addition, pharmacogenomics testing products aid physicians in individualizing and optimization of patient's therapeutic regimen. Pharmacogenomics and theranostics are paving the way for integrated medicine. Rapid evolution in this group of specialized molecular diagnostic tests are contributing in improvement for assessment of real-time treatment of disease.

However, presence of challenges pertaining to early integration of pharmacogenomic based testing into drug development time lines for gaining the approval simultaneously is anticipated to impede growth. Proper designing and implementation of clinical trials in order to identify individual as well as population variations from a given therapy has become a necessary attribute for the success of theranostics.

Further key findings from the report suggest:

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market Variables, Trends& Scope

4 Pharmacogenomics Technology: Therapeutic Area Estimates & Trend Analysis

5 Pharmacogenomics Technology: Technology Estimates & Trend Analysis

6 Pharmacogenomics Technology: Regional Estimates & Trend Analysis, by Therapeutic Area & Application

7 Competitive Landscape

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/cll8tw/pharmacogenomics

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716